Mr. Tibbitts will guide the company through its next phase of growth in the minimally invasive spine surgery market, according to a news release. He has more than 30 years of financial leadership experience.
He previously worked as CFO for Accriva Diagnostics, Accumetrics, CryoCor, and Elitra Pharmaceuticals. Mr. Tibbitts also held leadership roles with Ernst & Young and ITT Financial.
